UCB launches Eu2bn refi facility

Belgian biopharma group UCB has launched a Eu2bn loan to refinance part of the debt it took on to buy German rival Schwarz Pharma in 2006.

  • 26 Nov 2009

The facility is split into a Eu500m 364 day term loan and a Eu1.5bn three year revolver with an optional one year extension. The deal is being co-ordinated by BNP Paribas Fortis, Commerzbank and Mizuho.

The loan will partly refinance a Eu4bn acquisition facility taken out by UCB ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 3,865 12 12.28
2 Citi 2,800 7 8.90
3 Goldman Sachs 2,615 4 8.31
4 Credit Agricole 2,254 6 7.16
5 Barclays 2,006 6 6.38

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Bank of America Merrill Lynch 136,894.46 417 10.71%
2 Wells Fargo Securities 131,973.29 354 10.33%
3 Citi 128,092.49 391 10.02%
4 JPMorgan 109,675.50 340 8.58%
5 Credit Suisse 83,527.48 254 6.54%